메뉴 건너뛰기




Volumn 33, Issue 25, 2015, Pages 2753-2762

Feasibility of large-scale genomic testing to facilitate enrollment onto genomically matched clinical trials

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOCITRATE DEHYDROGENASE 1; ISOCITRATE DEHYDROGENASE 2; K RAS PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN KINASE B; PROTEIN P53; RAS PROTEIN; AKT1 PROTEIN, HUMAN; BRAF PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3CA PROTEIN, HUMAN; PTEN PROTEIN, HUMAN; TUMOR MARKER;

EID: 84941361474     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.4165     Document Type: Article
Times cited : (348)

References (10)
  • 1
    • 84888069767 scopus 로고    scopus 로고
    • OncoSeek: A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens
    • (abstr)
    • Routbort MJ, Handal BA, Patel KP, et al: OncoSeek: A versatile annotation and reporting system for next generation sequencing-based clinical mutation analysis of cancer specimens. J Mol Diagn 14:747, 2012 (abstr)
    • (2012) J Mol Diagn , vol.14 , pp. 747
    • Routbort, M.J.1    Handal, B.A.2    Patel, K.P.3
  • 2
    • 84882289495 scopus 로고    scopus 로고
    • Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes
    • Singh RR, Patel KP, Routbort MJ, et al: Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn 15:607-622, 2013
    • (2013) J Mol Diagn , vol.15 , pp. 607-622
    • Singh, R.R.1    Patel, K.P.2    Routbort, M.J.3
  • 3
    • 84901936604 scopus 로고    scopus 로고
    • Enabling a genetically informed approach to cancer medicine: A retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel
    • Johnson DB, Dahlman KH, Knol J, et al: Enabling a genetically informed approach to cancer medicine: A retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. Oncologist 19: 616-622, 2014
    • (2014) Oncologist , vol.19 , pp. 616-622
    • Johnson, D.B.1    Dahlman, K.H.2    Knol, J.3
  • 4
    • 84899837889 scopus 로고    scopus 로고
    • Concordance of genomic alterations between primary and recurrent breast cancer
    • Meric-Bernstam F, Frampton GM, Ferrer-Lozano J, et al: Concordance of genomic alterations between primary and recurrent breast cancer. Mol Cancer Ther 13:1382-1389, 2014
    • (2014) Mol Cancer Ther , vol.13 , pp. 1382-1389
    • Meric-Bernstam, F.1    Frampton, G.M.2    Ferrer-Lozano, J.3
  • 5
    • 84887491073 scopus 로고    scopus 로고
    • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
    • Frampton GM, Fichtenholtz A, Otto GA, et al: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 31:1023-1031, 2013
    • (2013) Nat Biotechnol , vol.31 , pp. 1023-1031
    • Frampton, G.M.1    Fichtenholtz, A.2    Otto, G.A.3
  • 6
    • 84922572706 scopus 로고    scopus 로고
    • Clinical next-generation sequencing in patients with non-small cell lung cancer
    • Hagemann IS, Devarakonda S, Lockwood CM, et al: Clinical next-generation sequencing in patients with non-small cell lung cancer. Cancer 121:631-639, 2015
    • (2015) Cancer , vol.121 , pp. 631-639
    • Hagemann, I.S.1    Devarakonda, S.2    Lockwood, C.M.3
  • 7
    • 84900829967 scopus 로고    scopus 로고
    • Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
    • Kris MG, Johnson BE, Berry LD, et al: Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA 311:1998-2006, 2014
    • (2014) JAMA , vol.311 , pp. 1998-2006
    • Kris, M.G.1    Johnson, B.E.2    Berry, L.D.3
  • 8
    • 84896730857 scopus 로고    scopus 로고
    • Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER)
    • André F, Bachelot T, Commo F, et al: Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: A multicentre, prospective trial (SAFIR01/UNICANCER). Lancet Oncol 15:267-274, 2014
    • (2014) Lancet Oncol , vol.15 , pp. 267-274
    • André, F.1    Bachelot, T.2    Commo, F.3
  • 9
    • 84859972424 scopus 로고    scopus 로고
    • Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials
    • Lovly CM, Dahlman KB, Fohn LE, et al: Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One 7:e35309, 2012
    • (2012) PLoS One , vol.7
    • Lovly, C.M.1    Dahlman, K.B.2    Fohn, L.E.3
  • 10
    • 84902583099 scopus 로고    scopus 로고
    • Physicians' attitudes about multiplex tumor genomic testing
    • Gray SW, Hicks-Courant K, Cronin A, et al: Physicians' attitudes about multiplex tumor genomic testing. J Clin Oncol 32:1317-1323, 2014
    • (2014) J Clin Oncol , vol.32 , pp. 1317-1323
    • Gray, S.W.1    Hicks-Courant, K.2    Cronin, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.